| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anesthesia, Sunnybrook & Womens College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Address correspondence to: Dr. Michael Gofeld, Department of Anesthesia, Sunnybrook & Womens College Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. Phone: 416-480-4864; Fax: 416-480-6039; E-mail: mgofeld{at}rogers.com
| Abstract |
|---|
|
|
|---|
Clinical findings: We present a case report where severe ischemic pain due to paraneoplastic Raynauds syndrome with distal gangrene was successfully treated by means of percutaneous thoracic sympathectomy. A unilateral T2, T3 radiofrequency sympathectomy combined with small volume phenol injection resulted in unexpected bilateral pain relief.
Conclusion: Our observations from this case report suggest a possible crossover of sympathetic innervation at the cervical and thoracic levels. Percutanenous thoracic radiofrequency sympathectomy is a feasible option for the treatment of refractory ischemic upper limb pain.
| Introduction |
|---|
|
|
|---|
Acute vascular occlusive events, such as Raynauds syndrome, are often accompanied by excruciating pain refractory to systemic analgesics. Sympathetic block and sympathectomy can have major roles for both nutritional blood flow restoration and pain control.6 Aggressive treatment of impending gangrene is of utmost importance. Percutaneous chemical and radiofrequency thoracic sympathectomy is a relatively simple, minimally invasive procedure, which might provide sustained pain relief.7 We report a case where unilateral radiofrequency sympathectomy was applied in the Acute Pain Service setting and lead to dramatic and lasting bilateral pain relief. Consent for anonymous publication of personal health information was obtained for publication in this document, in accordance with local institutional guidelines.
| Case report |
|---|
|
|
|---|
The patient had lost 20 pounds of weight and complained of "low energy" during the previous year. His regular medications consisted of clopidogrel, acetylsalicylic acid, omeprazole, quinapril, amlodipine, simvastatin and vitamin E. He had no known drug allergies.
Physical examination at the time of admission was remarkable for cyanotic and cold hands from metacarpal joints to fingertips. The second and the third fingertips were necrotic. Radial and ulnar pulses were bounding bilaterally. Emergent angiography was performed, which revealed arterial vascular occlusion in both hands, immediately distal to ulnar and radial arteries at the wrist. A working diagnosis of paraneoplastic vasculitis, Raynauds syndrome with distal necrosis was made.
A five-day course of epoprostenol iv infusions at a rate of 2 ng·kg1·min1, with a subsequent increase of 2 ng·kg1·min1 every 30 min to the maximal dose of 8 ng·kg1·min1 for four hours daily was initiated, with nitroglycerin ointment application over the forearm vessels. During the first three days, pain was poorly controlled despite oral dosing of hydromorphone up to 18 mg·day1 and acetaminophen 4 g·day1. His visual analogue scores for pain were 8/10. On day four, necrotic changes in several other distal phalanges appeared. The patient was exhausted, sleep deprived and in continuous pain. The Acute Pain Service was consulted and multimodal pain management initiated. The dose of hydromorphone was increased, while gabapentin 600 mg po daily, and nortriptyline 10 mg po at bedtime were added to the analgesic regimen. During the next five days, the pain was moderately controlled (visual analogue scores 5/10), but hydromorphone doses of 38 to 42 mg·day1 plus adjuvants caused excessive sedation.
Ten days after admission the patient was seen by the author (M.G.). A left-sided fluoroscopically guided stellate ganglion block at C7 was performed with bupi-vacaine 0.25% 5 mL. The patient preferred a left-sided procedure first, since he perceived slightly more severe pain on the left. Prior to a local anesthetic injection, 5 mL ionexol 300 mgI·mL1 was injected for radiological confirmation. Spread occurred in the typical anterolateral pattern over the C6 and C7 vertebrae without any caudal extension. Signs of Horners syndrome lasted approximately two hours, and greater than 50% pain reduction was noted for six hours. It was assumed that the pain relief would only occur on the ipsilateral side of the block, and so he was not questioned at this time about contralateral pain relief. Daily hydromorphone consumption decreased to 26 mg.
Subsequently, a T2 and T3 radiofrequency sympathectomy was performed. A chemical stellate ganglion neurolysis was thought to be unsafe due to the history of a previous surgery and a high probability of unpredictable spread of phenol. Two days later, a left-sided T2 and T3 radiofrequency sympathectomy was performed. Two RFK (20 G, 100/10 mm) curved blunt-tipped electrodes (Baylis Medical, Montreal, QC, Canada) were inserted as described elsewhere8 (Figure 1
). A radiofrequency generator (Baylis Medical PMG-115, Montreal, Canada) was used. Sensory stimulation at 50 Hz, 1.2 V elicited a vague sensation over the left arm and forearm. Motor stimulation at 2 Hz, up to 2.5 V, evoked no intercostal contractions, thus the active tip was positioned properly, far enough from the exiting ventral nerve root. Following verification of the electrode tip position by injection of 2 mL ionexol 300 mgI·mL1, two sets of radiofrequency lesions with electrode rotation cephalad and caudad at 80°C, 75 sec each, were performed. No sedation was needed. Next, 1 mL aqueous phenol 10% was injected slowly through each electrode. The electrodes were then flushed with isotonic saline and removed.
|
|
| Discussion |
|---|
|
|
|---|
Another reason for pain relief unrelated to sympathetic regulation of the vascular tone may be hypothesized. Sympathetic nerve terminals in peripheral tissues may serve as mediator elements in hyperalgesia.10 Some of the postganglionic sympathetic fibres return to the dorsal horn via gray rami communicants, while others travel up and down along the sympathetic trunk to terminate in remote ganglia. These fibres may play a role in an afferent conduction much similar to the afferent conduction of visceral pain through a sympathetic pathway. One may speculate that interconnections exist between these fibres and dorsal horn neurons, with subsequent pain projection through ipsilateral and contralateral tracts. There is evidence that such a pathway exists in animals.11 Afferent sympathetic fibre conduction block and subsequent pain propagation cross-inhibition at the spinal or supraspinal level might be responsible for analgesia. Further neuroanatomical studies would be required to confirm such a hypothesis.
Thoracic sympathetic blockade has been used for the past 80 years to manage painful conditions and vascular insufficiency of the upper extremities. Proximity of the thoracic sympathetic ganglia to the intercostal nerves and neuroforamina have resulted in a high rate of neurological complications.8 Large volume injectate and utilization of a "blind" technique likely contributed to many of these complications. Eventually, chemical sympathectomy was abandoned. More recently, the technique has been reintroduced. Phenol injections using low volumes under fluoroscopic guidance have been reported to be successful, with only minor side effects.12
There are a number of potential indications for thoracic sympathetic blockade and sympathectomy including: complex regional pain syndrome, ischemic and vasospastic painful conditions, frostbite, hyperhidrosis and malignant and non-malignant thoracic visceral pain.
Despite a high rate of recurrence, when implemented in Raynauds syndrome, thoracic sympathectomy clearly produced a high success rate and showed potential for reducing the severity of refractory symptoms.7 Although total flow is not significantly increased, peripheral sympathectomy increases the nutritional flow and appears to improve abnormal arteriovenous shunting and microcirculation in ischemic areas.6
Wilkinson first described the technique of percutaneous thoracic radiofrequency sympathectomy in 1984. In 1996, the first large prospective study of this technique was published. Although the trial was an open label study, the results were encouraging and favourably compared with thoracic endoscopic sympathectomy.13 However, the technique was criticized as time-consuming, and questionable with respect to long-term results.14 The procedure has since been modified using blunt-tipped curved radiofrequency electrodes.15 This modification permits better "steering", increases the lesion area, and reduces the complications of intercostal nerve injury and pneumothorax. In a recent series of 1,742 cases of hyperhidrosis, the authors concluded that the modified technique is associated with good long-term results and a low complication rate. Similar outcomes were obtained when the sympathectomy was performed at the T2 and T3 levels, or at the T2 level only.16
The basic principle for radiofrequency ablation of a sympathetic lesion involves accuracy and precision. Sensory electrical stimulation occasionally elicits either a vague sensation or pain at the target area. Motor stimulation usually serves as an indicator of sufficient distance from the ventral root. Absence of motor stimulation at a current setting twice that of sensory stimulation is thought to be appropriate to avoid a nerve root heat injury. To maximize the probability of success, the radiofrequency electrode must be located as close to the sympathetic ganglion as possible. According to the anatomical study of Wilkinson, the T2 ganglion is situated roughly in the middle of the vertebrae rostro-caudally and 1/3 dorso-ventrally.17 Others have indicated that approximately 90% of the T2 or T3 sympathetic trunks are located on the head of the corresponding rib.18 A recent study found that the second thoracic ganglion is usually located (in 92.5% of patients) in the second intercostal space at the level of the intervertebral disc, between the second and the third thoracic vertebrae.19 Although a variation of 11.5 cm is not of great importance during a surgical sympathectomy, it is critical during radiofrequency electrode placement. Therefore, we usually combine the radiofrequency lesion with a small volume of phenol.
In conclusion, percutaneous thoracic radiofrequency sympathectomy is feasible for the treatment of refractory ischemic upper limb pain, and our observations from this case suggest a possible crossover of sympathetic innervation at the cervical and thoracic levels.
| Acknowledgments |
|---|
| Footnotes |
|---|
Accepted for publication September 11, 2005. Revision accepted October 13, 2005. Final revision accepted November 16, 2005.
| References |
|---|
|
|
|---|
2 Lu K, Liang CL, Cho CL, et al. Patterns of palmar skin temperature alterations during transthoracic endoscopic T2 sympathectomy for palmar hyperhidrosis. Auton Neurosci 2000; 86: 99106.[Medline]
3 Hogan QH, Taylor ML, Goldstein M, Stevens R, Kettler R. Success rates in producing sympathetic blockade by paratracheal injection. Clin J Pain 1994; 10: 13945.[Medline]
4 Allen G, Samson B. Contralateral Horners syndrome following stellate ganglion block (Letter). Can Anaesth Soc J 1986; 33: 1123.[Medline]
5 Valley MA, Rogers JN, Gale DW. Relief of recurrent upper extremity sympathetically-maintained pain with contralateral sympathetic blocks: evidence for crossover sympathetic innervation? J Pain Symptom Manage 1995; 10: 396400.[Medline]
6 Koman LA, Smith BP, Pollock FE Jr, Smith TL, Pollock D, Russell GB. The microcirculatory effects of peripheral sympathectomy. J Hand Surg (Am) 1995; 20: 70917.[Medline]
7 Matsumoto Y, Ueyama T, Endo M, et al. Endoscopic thoracic sympathectomy for Raynauds phenomenon. J Vasc Surg 2002; 36: 5761.[Medline]
8 Raj PP, Lou L, Erdine S, Staats PS. T2 and T3 sympathetic nerve block and neurolysis. In: Raj PP, Lou L, Erdine S, Staats PS (Eds). Radiographic Imaging for Regional Anesthesia and Pain Management. Philadelphia: Churchill Livingstone; 2003: 1327.
9 Wallace MS, Milholland AV. Contralateral spread of local anesthetic with stellate ganglion block. Reg Anesth 1993; 18: 559.[Medline]
10 Janig W, Levine JD, Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996; 113: 16184.[Medline]
11 Foreman RD, Blair RW, Weber RN. Viscerosomatic convergence onto T2T4 spinoreticular, spinoreticular-spinothalamic, and spinothalamic tract neurons in the cat. Exp Neurol 1984; 85: 597619.[Medline]
12 Wang YC, Wei SH, Sun MH, Lin CW. A new mode of percutaneous upper thoracic phenol sympatholysis: report of 50 cases. Neurosurgery 2001; 49: 62836.[Medline]
13 Wilkinson HA. Percutaneous radiofrequency upper thoracic sympathectomy. Neurosurgery 1996; 38: 71525.[Medline]
14 Kao MC. Percutaneous radiofrequency upper thoracic sympathectomy (Letter). Neurosurgery 1997; 40: 2167.[Medline]
15 Stanton-Hicks M. Radiofrequency procedures in the thoracic region. Tech Region Anesth Pain Manage 2004; 8: 29.
16 Chuang KS, Liu JC. Long-term assessment of percutaneous stereotactic thermocoagulation of upper thoracic ganglionectomy and sympathectomy for palmar and craniofacial hyperhidrosis in 1742 cases. Neurosurgery 2002; 51: 9639.[Medline]
17 Yarzebski JL, Wilkinson HA. T2 and T3 sympathetic ganglia in the adult human: a cadaver and clinical-radiographic study and its clinical application. Neurosurgery 1987; 21: 33942.[Medline]
18 Wang YC, Sun MH, Lin CW, Chen YJ. Anatomical location of T2-3 sympathetic trunk and Kuntz nerve determined by transthoracic endoscopy. J Neurosurg 2002; 96: 6872.[Medline]
19 Singh B, Ramsaroop L, Partab P, Moodley J, Satyapal KS. Anatomical variations of the second thoracic ganglion. Surg Radiol Anat 2005; 27: 11922.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |